[HTML] nih.gov

[HTML][HTML] World Heart Federation roadmap for secondary prevention of cardiovascular disease: 2023 update

L Laranjo, F Lanas, MC Sun, DA Chen, L Hynes… - Global …, 2024 - ncbi.nlm.nih.gov
Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …
被引用次数：7 相关文章

World Heart Federation Roadmap for secondary prevention of cardiovascular disease: 2023 update

RT David, L Laranjo - Global Heart, 2024 - pure.qub.ac.uk
Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …

World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update

L Laranjo, F Lanas, MC Sun, DA Chen… - Global …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …

World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update

L Laranjo, F Lanas, M Sun, D Chen, L Hynes, T Imran… - Global Heart, 2024 - europepmc.org
Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …
[HTML] globalheartjournal.com

[HTML][HTML] World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update

L Laranjo, F Lanas, MC Sun, DA Chen… - Global …, 2024 - globalheartjournal.com
Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …

World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update

L Laranjo, F Lanas, M Sun, D Chen, L Hynes… - Global …, 2024 - avesis.hacettepe.edu.tr
Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …

World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update.

L Laranjo, F Lanas, MC Sun, DA Chen, L Hynes… - Global Heart, 2024 - europepmc.org
Secondary prevention lifestyle and pharmacological treatment of atherosclerotic
cardiovascular disease (ASCVD) reduce a high proportion of recurrent events and mortality …
[HTML] globalheartjournal.com

[HTML][HTML] World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update

L Laranjo, F Lanas, MC Sun, DA Chen… - Global …, 2024 - globalheartjournal.com
Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …